AMPULLA OF VATER CARCINOMA
Clinical trials for AMPULLA OF VATER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new AMPULLA OF VATER CARCINOMA trials appear
Sign up with your email to follow new studies for AMPULLA OF VATER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy drug dostarlimab takes on chemo in phase 2 trial
Disease control Recruiting nowThis phase 2 trial is testing whether the immunotherapy drug dostarlimab can work better than standard chemotherapy as a first treatment for people with rare, advanced cancers that have a specific genetic flaw called dMMR/MSI. The study includes 120 adults with cancers like pancr…
Matched conditions: AMPULLA OF VATER CARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New algorithm aims to keep chemo on track for stomach and colon cancers
Symptom relief Recruiting nowThis study tests whether a special algorithm called PAGODA can reduce unplanned delays during FOLFOX chemotherapy for gastrointestinal cancers like colon, stomach, and esophageal cancer. About 420 participants will be randomly assigned to either standard care or the algorithm-gui…
Matched conditions: AMPULLA OF VATER CARCINOMA
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC